Michael Bennett
21Patents
11h-index
35Co-inventors
75Inventor score
Filing activity: Feb 16, 1993 → Nov 4, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5346907A | Amino acid analog CCK antagonists | Chemistry; Metallurgy | 51 | Expired |
| US5527928A | Cationic transport reagents | Chemistry; Metallurgy | 41 | Expired |
| US5824812A | Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin: polynucleotide transfection complexes | Chemistry; Metallurgy | 33 | Expired |
| US5744625A | Cationic transport reagents | Chemistry; Metallurgy | 26 | Expired |
| US5869715A | Polyfunctional cationic cytofectins | Chemistry; Metallurgy | 23 | Expired |
| US9034900B2 | Bromodomain inhibitors | Chemistry; Metallurgy | 23 | Active |
| US5892071A | Cationic transport reagents | Chemistry; Metallurgy | 19 | Expired |
| US5925623A | Formulations and methods for generating active cytofectin: polynucleotide transfection complexes | Chemistry; Metallurgy | 18 | Expired |
| US7132533B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | Chemistry; Metallurgy | 15 | Expired |
| US7462713B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | Chemistry; Metallurgy | 13 | Active |
| US6967198B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | Chemistry; Metallurgy | 11 | Expired |
| US9115114B2 | Bromodomain inhibitors | Chemistry; Metallurgy | 10 | Active |
| US6372722B1 | Method for nucleic acid transfection of cells | Chemistry; Metallurgy | 4 | Expired |
| US10883103B2 | Compositions and methods for delivery of a polynucleotide into a plant | Chemistry; Metallurgy | 3 | Active |
| US10807982B2 | Bromodomain inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9908885B2 | Bromodomain inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10494371B2 | Bromodomain inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10202360B2 | Therapeutic compounds | Chemistry; Metallurgy | 1 | Active |
| US11807857B2 | Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression | Chemistry; Metallurgy | 0 | Active |
| US6025358A | Double prodrugs of potent GP IIb/IIIa antagonists | Chemistry; Metallurgy | 0 | Expired |
| US6624149B2 | Method for nucleic acid transfection of cells | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.